EMJ Podcast: Insights For Healthcare Professionals

Järvinen-Seppo discusses how translational research is advancing understanding of early allergic disease, from maternal antibodies to global collaborations shaping the future of prevention and care.

Timestamps:

00:57 – Research scope

03:49 – Maternal antibodies

07:34 – Integrating new evidence

09:17 – International coordination

10:37 – Emerging areas

This episode examines the spectrum of food allergy, from IgE-mediated disease to food protein induced enterocolitis syndrome and eosinophilic conditions, and explores how diet, skin barrier function, and the microbiome interact in early life.

Timestamps:

00:53 – Spectrum of allergic diseases

05:00 – Nutrition and immune activation

07:22 – Atopic dermatitis

08:55 – IgE-mediated food allergy

10:28 – Future management pathways

In this episode of Onc Now, Claire Snyder explores the growing importance of patient-reported outcomes and quality of life in modern oncology care. She discusses the challenges and opportunities of integrating patient perspectives into routine practice, as well as the global effort to standardise these measures through initiatives such as the PROTEUS Consortium. The conversation also highlights the evolving needs of survivors of cancer, key priorities in survivorship care, and what the future holds for patient-centred oncology.

Timestamps:

00:00 – Introduction

01:41 – Modern oncology care

03:56 – Patient-reported outcomes (PRO) interest origin

05:10 - PRO implementation challenges

06:36 - PROTEUS Consortium mission

08:33 - Survivorship care priorities

09:45 - Childhood survivor insights

12:35 - Advice for newcomers

13:37 - Future quality of life developments

14:41 - Three wishes

Kirsi Järvinen-Seppo explores how the infant immune system develops, highlighting the role of maternal environment, breast milk composition, and early-life exposures in shaping allergy risk.

Timestamps:

00:57 – Infant immune system

02:06 – Maternal lifestyle factors

06:10 – Breast milk composition

10:13 – ESCAPE study

13:25 – Early sensitisation pathways

16:58 – Early risk stratification

In this rapid-fire episode, Kirsi Järvinen-Seppo tackles key questions on infant immune development, common misconceptions around food allergy, and the early-life factors that shape allergic disease. She also highlights emerging research on maternal influences, breast milk immunology, and prevention strategies that could transform clinical practice.

In the final deep dive, Cherry Lim looks ahead to the future of AMR surveillance. She discusses the role of microbiology labs, the value of imperfect datasets, and how integrating genomics, modelling, and cost-effectiveness could transform global health systems over the next two decades.

Timestamps

00:00 – Introduction

01:03 – Investing in diagnostics 02:36 – Routine surveillance data 03:53 – Global versus local AMR data 05:08 – Future health systems

In this second deep dive episode, Cherry Lim discusses how complex modelling approaches can translate into practical clinical insights. From counterfactual frameworks to real-world prescribing decisions, she explores how data-driven tools can support clinicians in choosing more effective antibiotic treatments.

Timestamps

00:00 – Introduction

01:03 – Understanding counterfactual frameworks

02:56 – Antibiotic choice and survival

05:08 – Clinical decision dashboards

06:24 – Assumptions in AMR modelling

In this episode of Hema Now, Marilyn Manco-Johnson explores the evolution and future of paediatric haemophilia care. From the early adoption of prophylactic treatment to today's rapidly advancing therapeutic landscape, she reflects on the milestones that have transformed outcomes for children. The conversation also dives into ongoing challenges, including joint health, variability in treatment response, and access to care, while highlighting emerging innovations such as gene therapy and non-factor therapies that could redefine long-term management.

Timestamps:

00:00 – Introduction

00:49 - Career inspiration

04:40 - Prophylaxis turning points

09:41 - Key care advances

12:12 - Current research questions

15:00 - Joint risk factors

19:10 - Emerging therapies impact

24:24 – Recognising joint pain

26:08 - Gaps in care

29:11 - Future priorities

In this first deep dive, Lim explores how routine hospital data and bacterial genomics are transforming our understanding of AMR. She explains how combining datasets and transmission models can uncover hidden pathways of resistance and highlights the challenges of working across diverse healthcare settings.